In contrast to the hepatoprotective role of CAR, in a NASH mouse model, Car-/- mice did not show altered lipid levels but a decreased level of serum ALT and decreased lipid peroxidation in the liver, suggesting a rather detrimental role of CAR in lipid metabolism [116]. This evidence concerns the gene NR1I3 and metabolic dysfunction-associated steatohepatitis.